Discover preclinical studies that indicate that empagliflozin reduces liver fat, improves liver function markers, and ...

High-intensity interval training was associated with improved glycemic control and cardiometabolic outcomes among patients with type 2 diabetes.

"The findings showed that elevated PAI-1 levels in individuals without diabetes may serve as an early indicator of type 2 ...

Empagliflozin patent expiration in India leads to affordable treatment for diabetes, heart failure, and kidney disease.

Continuing our series highlighting recent presentations from Nursing in Practice 365 events, diabetes specialist midwife ...

Background Effective management of coexisting heart failure (HF), chronic kidney disease (CKD) and type 2 diabetes mellitus ...

The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...

The researchers highlighted the importance of incorporating the Trabecular Bone Score alongside aBMD assessments for a more ...

Alkem Laboratories on Wednesday said it has launched a generic medication for the treatment of type-2 diabetes mellitus, ...

Glenmark Pharmaceuticals on Wednesday said it has launched a medication for glycemic control and weight-loss for diabetes ...

Vagal Neuromodulation Provides Route to Treat Type 2 Diabetes and HypoglycemiaIRVINE, Calif., March 10, 2025 (GLOBE NEWSWIRE) ...